Results 241 to 250 of about 55,450 (274)
Some of the next articles are maybe not open access.

Topical botulinum toxin

2016
Nanotechnology is a rapidly growing discipline that capitalizes on the unique properties of matter engineered on the nanoscale. Vehicles incorporating nanotechnology have led to great strides in drug delivery, allowing for increased active ingredient stability, bioavailability, and site-specific targeting. Botulinum toxin has historically been used for
Ashley Collins, Adnan Nasir
openaire   +3 more sources

Botulinum Toxin A

2012
There is a trend toward greater use of cosmetic procedures by ethnic minorities. The greatest level of increased interest is among Latino and African American patients, with Latino patients leading all minority groups in the number of cosmetic procedures performed in 2008.
Carlos A. Charles, Elena Jones
openaire   +2 more sources

Botulinum Toxin A

2001
Bereits der Name Botulinum Toxin A verrat viel uber die Historie einer Substanz, die in den letzten Jahren eine sprunghafte Karriere vom Gift zum Arzneimittel erfahren hat. Bekannt geworden ist das Toxin als Verursacher des Botulismus, einer Lebensmittelvergiftung, die durch verdorbene Wurst- und Konservenwaren (Botulus lat.
Mall, Volker   +4 more
openaire   +3 more sources

Botulinum Toxin for Rhinitis

Current Allergy and Asthma Reports, 2016
Rhinitis is a common clinical entity. Besides nasal obstruction, itching, and sneezing, one of the most important symptoms of rhinitis is nasal hypersecretion produced by nasal glands and exudate from the nasal vascular bed. Allergic rhinitis is an IgE-mediated inflammatory reaction of nasal mucosa after exposure to environmental allergens.
Cengiz Özcan, Onur Ismi
openaire   +3 more sources

Botulinum Toxin and Pain

2020
This chapter is focused on analgesic mechanism of action of botulinum toxin type A (BoNT-A) including the action beyond peripheral nerve endings. With the exception of the meninges and possibly urinary bladder, the presence of BoNT-A activity in the periphery, cleaving SNAP25 as a target molecule, up to now was not convincingly shown.
openaire   +3 more sources

Pharmacology of botulinum toxin

Journal of the American Academy of Dermatology, 2000
Botulinum toxin has a well-defined role among dermatologists for the treatment of facial wrinkling, brow position, and palmar and axillary hyperhidrosis.The purpose of this study is to educate dermatologists on the pharmacology of botulinum toxin.A retrospective review of the literature on botulinum toxin from 1962 to the present was conducted.
Wilber Huang   +2 more
openaire   +2 more sources

Periocular botulinum toxin

Clinics in Dermatology, 2003
Botulinum toxin type A (BOTOX, Dysport) has revolutionized treatment of wrinkles around the eyes. Since the first publications of its cosmetic benefit by Drs. Jean and Alastair Carruthers, hundreds of articles have been published about its cosmetic use. BOTOX holds U.S.
openaire   +3 more sources

Botulinum Toxin in Ophthalmology

Survey of Ophthalmology, 2007
Since its introduction into clinical medicine in 1980, botulinum toxin has become a major therapeutic drug with applications valuable to many medical sub-specialties. Its use was spearheaded in ophthalmology where its potential applications have expanded to cover a broad range of visually related disorders.
Amy M. Fowler, Jonathan J. Dutton
openaire   +3 more sources

Botulinum Toxin Therapy

Neurologic Clinics, 1991
Botulinum toxin therapy has emerged as a treatment modality for a variety of spastic- or contracture-related muscle diseases. Its safety has been proven for long-term use in the treatment of benign essential blepharospasm, hemifacial spasm, and certain types of strabismus. Recent approval from the Federal Drug Administration should make botulinum toxin
Marlon Maus   +2 more
openaire   +3 more sources

Browlift with Botulinum Toxin

Dermatologic Surgery, 2000
Botulinum toxin has been used successfully for the treatment of hyperfunctional facial lines.To determine the alteration in brow position after botulinum toxin treatment of the brow depressor muscles.Eleven women, 30-60 years old, were treated. Prior to treatment, brow position was measured relative to the pupil.
Jill A. Foster   +2 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy